Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.09.052Source: DataRank Database

Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.29)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Virender Kumar ORCID,Svetlana Romanova ORCID,Jitender Bariwal ORCID,Hao Chen ORCID,Shanshan Deng ORCID

Live enrichment

PubMed:33010334 PMC:PMC7904572 OpenAlex:https://openalex.org/W3090401588

NIGMS NIH HHS

Grant: P30 GM127200

NIH HHS

Grant: S10 OD010678

NIGMS NIH HHS

Grant: U54 GM115458

NCI NIH HHS

Grant: R01 CA148706

NCRR NIH HHS

Grant: S10 RR026377

National Institutes of Health

Grant: 3U54GM115458-07S2

Great Plains IDeA-CTR

National Institutes of Health

Grant: 5R01CA148706-10

Targeting the colchicine site in tubulin for advanced melanoma

National Institutes of Health

FWCI

0.29

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7904572

publisherhttps://api.elsevier.com/content/article/PII:S016836592030568X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S016836592030568X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2020.09.052

Fields of Study

Nanoparticle-Based Drug DeliveryCancer Research and TreatmentsCancer, Lipids, and Metabolism0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsCell Line, TumorMiceMicellesNanoparticlesPancreatic NeoplasmsPolyethylene GlycolsPolymersTubulin Modulators

MeSH Terms

AnimalsMicellesPancreatic NeoplasmsPolyethylene GlycolsPolymersCell Line, TumorTubulin ModulatorsMiceNanoparticles

Keywords

ChemistryPancreatic cancerTubulinBiophysicsStereochemistryMicrotubuleCancerMedicineBiologyCell biologyNanoparticlesTubulin InhibitorLipid-drug ConjugatePancreatic NeoplasmsMicePolymersCell Line, TumorAnimalsMicellesTubulin ModulatorsPolyethylene Glycols

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer

FAIR Checklist

Authors (10)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)